Approval requires documented BMI of 30 kg/m or higher, or BMI of 27 kg/m with weight-related comorbidities such as hypertension or type 2 diabetes
In addition to its anti-diabetic and anti-obesity effects, myricetin also has anti-cancer, anti-inflammatory effects, cardiovascular and hepatoprotective effects
For most patients this is clinically irrelevant, but if you're titrating slowly or have a history of dose-sensitive side effects, request a syringe with half-unit markings
However, the limit to its reuse depends on several factors
Some benefits may persist, particularly if you've made lasting changes in body composition or established better sleep patterns
For pilot studies, method development, or any protocol that will not consume 100mg inside a sensible in-use window, the smaller vial is the technically preferable choice rather than merely the cheaper one